Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2019-08-26
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BCI for Hemiparetic Upper Extremities in Patients Due to Stroke
NCT05778448
EEG Based BCI for Upper Limb Rehabilitation in Stroke
NCT04188132
Effects of Home-based Neurostimulation Associated With Motor Training in Chronic Stroke Patients
NCT01034150
Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients
NCT03947645
Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis
NCT00170716
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be assessed by blinded raters before and after the intervention and 3 months post stroke. Main endpoint will be UL motor function assessed by Action Research Arm Test (ARAT) at 3 months post stroke. Other outcome measures comprise Fugl Meyer Motor Assessment and Functional Independence Measure. The patients and therapists' experience with this type of training will be evaluated with questionnaires and interviews.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BCI training
Patients randomized to this group will receive up to12 (minimum 8) sessions of BCI training with the RecoveriX system (gtec, Austria). The system combines EEG driven functional electrical stimulation with visual feedback. BCI training is provided as a part of standard training of the impaired upper limb.
Brain Computer Interface training
Training with RecoveriX system.
Control
Patients randomized to this control group will receive standard physiotherapy and occupational therapy for their impaired upper limb.
Control
Standard physiotherapy and occupational therapy according to clinical routines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brain Computer Interface training
Training with RecoveriX system.
Control
Standard physiotherapy and occupational therapy according to clinical routines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 15 days to 60 days (+/- 3) after stroke onset
* Severe paresis or paralysis defined as \< 13 on Action Research arm Test (ARAT)
* Able to give informed consent
* Able to comply with treatment protocol.
Exclusion Criteria
* Psychiatric / behavioral conditions that interfere with compliance to the protocol, epilepsy
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hammel Neurorehabilitation Centre and University Research Clinic
OTHER
Sygekassernes Helsefond
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iris Brunner, PhD
Role: PRINCIPAL_INVESTIGATOR
Aarhus University, Hammel Neurocenter
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hammel Neurorehabilitation Centre and University Research Clinic
Hammel, Aarhus, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
649780
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.